Inventor · disambiguated record
Hongyan Zhou
Also filed as: ZHOU HONGYAN
5 granted patents·5 pending applications·58 citations·filing 2009–2025
81Inventor score
Top patents by PatentIndex Score
10 records- 0192US8906677B2Generation and maintenance of stem cellsLI WENLIN·Filed 2009·Granted Dec 9, 2014·34 cites·20 claims
- 0287US9540615B2Combined chemical and genetic approaches for generation of induced pluripotent stem cellsSCRIPPS RESEARCH INST·Filed 2013·Granted Jan 10, 2017·7 cites·9 claims
- 0387US9534205B2Combined chemical and genetic approaches for generation of induced pluripotent stem cellsSHI YAN·Filed 2009·Granted Jan 3, 2017·8 cites·14 claims
- 0484US9068170B2Generation of pluripotent stem cells using recombinant proteinsZHOU HONGYAN·Filed 2010·Granted Jun 30, 2015·9 cites·14 claims
- 0564US9926533B2Combined chemical and genetic approaches for generation of induced pluripotent stem cellsSCRIPPS RESEARCH INST·Filed 2016·Granted Mar 27, 2018·0 cites·15 claims
- 0664US2018171303A1Combined chemical and genetic approaches for generation of induced pluripotent stem cellsSCRIPPS RESEARCH INST·Filed 2018·Application pending·0 cites
- 0760US2024197747A1Treatment of viral infections with combination of pikfyve kinase inhibitors and tmprss-2 inhibitorsACURASTEM INC·Filed 2023·Application pending·0 cites
- 0856US2021033597A1Method for identifying effective treatments against neurodegenerative disordersAcuraStem Incorporated·Filed 2019·Application pending·0 cites
- 0952US2025377351A1Method for identifying effective treatments against neurodegenerative disordersAcuraStem Incorporated·Filed 2025·Application pending·0 cites
- 1049US2021338683A1Treatment of viral infections with combination of pikfyve kinase inhibitors and tmprss-2 inhibitorsACURASTEM INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hongyan Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →